カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の線維筋痛症治療薬市場2022年：シンバルタ（デュロキセチン）、サベラ（ミルナシプラン）、リリカ（プレガバリン）、パンクロニウム、その他

◆英語タイトル：Global Fibromyalgia Therapeutics Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8820）◆商品コード：GIR22MY8820
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：118
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

線維筋痛症治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の線維筋痛症治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

線維筋痛症治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・シンバルタ（デュロキセチン）、サベラ（ミルナシプラン）、リリカ（プレガバリン）、パンクロニウム、その他

用途別セグメントは次のように区分されます。
・病院、クリニック、その他

世界の線維筋痛症治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Eli Lilly、Actavis、Merck Sharp and Dohme、Daiichi Sankyo、Innovative Med Concepts、Meda、Meiji Seika、Switch Biotech、Theravance、Zynerba Pharmaceuticals、Tonix Pharmaceuticals Holding Corp. (TNXP)、Daiichi Sankyo、Forest Pharmaceuticals, Inc.、Boehringer Ingelheim GmbH、Pierre Fabre Mdicament

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、線維筋痛症治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な線維筋痛症治療薬メーカーの企業概要、2019年～2022年までの線維筋痛症治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な線維筋痛症治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別線維筋痛症治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの線維筋痛症治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での線維筋痛症治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および線維筋痛症治療薬の産業チェーンを掲載しています。
・第13、14、15章では、線維筋痛症治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Eli Lilly、Actavis、Merck Sharp and Dohme、Daiichi Sankyo、Innovative Med Concepts、Meda、Meiji Seika、Switch Biotech、Theravance、Zynerba Pharmaceuticals、Tonix Pharmaceuticals Holding Corp. (TNXP)、Daiichi Sankyo、Forest Pharmaceuticals, Inc.、Boehringer Ingelheim GmbH、Pierre Fabre Mdicament
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：シンバルタ（デュロキセチン）、サベラ（ミルナシプラン）、リリカ（プレガバリン）、パンクロニウム、その他
・用途別分析2017年-2028年：病院、クリニック、その他
・線維筋痛症治療薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・線維筋痛症治療薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・線維筋痛症治療薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・線維筋痛症治療薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・線維筋痛症治療薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Fibromyalgia Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Fibromyalgia Therapeutics Drugs market size is estimated to be worth US$ 2945.2 million in 2021 and is forecast to a readjusted size of USD 3308.4 million by 2028 with a CAGR of 1.7% during review period. Hospital accounting for % of the Fibromyalgia Therapeutics Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cymbalta (Duloxetine) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Fibromyalgia Therapeutics Drugs include Pfizer, Eli Lilly, Actavis, Merck Sharp and Dohme, and Daiichi Sankyo, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Fibromyalgia Therapeutics Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cymbalta (Duloxetine)
Savella (Milnacipran)
Lyrica (Pregabalin)
Pancuronium
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Fibromyalgia Therapeutics Drugs market are listed below:
Pfizer
Eli Lilly
Actavis
Merck Sharp and Dohme
Daiichi Sankyo
Innovative Med Concepts
Meda
Meiji Seika
Switch Biotech
Theravance
Zynerba Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. (TNXP)
Daiichi Sankyo
Forest Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Pierre Fabre Mdicament
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fibromyalgia Therapeutics Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fibromyalgia Therapeutics Drugs, with price, sales, revenue and global market share of Fibromyalgia Therapeutics Drugs from 2019 to 2022.
Chapter 3, the Fibromyalgia Therapeutics Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fibromyalgia Therapeutics Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Fibromyalgia Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fibromyalgia Therapeutics Drugs.
Chapter 13, 14, and 15, to describe Fibromyalgia Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Fibromyalgia Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fibromyalgia Therapeutics Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Cymbalta (Duloxetine)
1.2.3 Savella (Milnacipran)
1.2.4 Lyrica (Pregabalin)
1.2.5 Pancuronium
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Fibromyalgia Therapeutics Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Fibromyalgia Therapeutics Drugs Market Size & Forecast
1.4.1 Global Fibromyalgia Therapeutics Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Fibromyalgia Therapeutics Drugs Sales in Volume (2017-2028)
1.4.3 Global Fibromyalgia Therapeutics Drugs Price (2017-2028)
1.5 Global Fibromyalgia Therapeutics Drugs Production Capacity Analysis
1.5.1 Global Fibromyalgia Therapeutics Drugs Total Production Capacity (2017-2028)
1.5.2 Global Fibromyalgia Therapeutics Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fibromyalgia Therapeutics Drugs Market Drivers
1.6.2 Fibromyalgia Therapeutics Drugs Market Restraints
1.6.3 Fibromyalgia Therapeutics Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Fibromyalgia Therapeutics Drugs Product and Services
2.1.4 Pfizer Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Fibromyalgia Therapeutics Drugs Product and Services
2.2.4 Eli Lilly Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Actavis
2.3.1 Actavis Details
2.3.2 Actavis Major Business
2.3.3 Actavis Fibromyalgia Therapeutics Drugs Product and Services
2.3.4 Actavis Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck Sharp and Dohme
2.4.1 Merck Sharp and Dohme Details
2.4.2 Merck Sharp and Dohme Major Business
2.4.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product and Services
2.4.4 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Daiichi Sankyo
2.5.1 Daiichi Sankyo Details
2.5.2 Daiichi Sankyo Major Business
2.5.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product and Services
2.5.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Innovative Med Concepts
2.6.1 Innovative Med Concepts Details
2.6.2 Innovative Med Concepts Major Business
2.6.3 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product and Services
2.6.4 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Meda
2.7.1 Meda Details
2.7.2 Meda Major Business
2.7.3 Meda Fibromyalgia Therapeutics Drugs Product and Services
2.7.4 Meda Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Meiji Seika
2.8.1 Meiji Seika Details
2.8.2 Meiji Seika Major Business
2.8.3 Meiji Seika Fibromyalgia Therapeutics Drugs Product and Services
2.8.4 Meiji Seika Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Switch Biotech
2.9.1 Switch Biotech Details
2.9.2 Switch Biotech Major Business
2.9.3 Switch Biotech Fibromyalgia Therapeutics Drugs Product and Services
2.9.4 Switch Biotech Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Theravance
2.10.1 Theravance Details
2.10.2 Theravance Major Business
2.10.3 Theravance Fibromyalgia Therapeutics Drugs Product and Services
2.10.4 Theravance Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Zynerba Pharmaceuticals
2.11.1 Zynerba Pharmaceuticals Details
2.11.2 Zynerba Pharmaceuticals Major Business
2.11.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product and Services
2.11.4 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
2.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Details
2.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Major Business
2.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product and Services
2.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Daiichi Sankyo
2.13.1 Daiichi Sankyo Details
2.13.2 Daiichi Sankyo Major Business
2.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product and Services
2.13.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Forest Pharmaceuticals, Inc.
2.14.1 Forest Pharmaceuticals, Inc. Details
2.14.2 Forest Pharmaceuticals, Inc. Major Business
2.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product and Services
2.14.4 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Boehringer Ingelheim GmbH
2.15.1 Boehringer Ingelheim GmbH Details
2.15.2 Boehringer Ingelheim GmbH Major Business
2.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product and Services
2.15.4 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Pierre Fabre Mdicament
2.16.1 Pierre Fabre Mdicament Details
2.16.2 Pierre Fabre Mdicament Major Business
2.16.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product and Services
2.16.4 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Fibromyalgia Therapeutics Drugs Breakdown Data by Manufacturer
3.1 Global Fibromyalgia Therapeutics Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Fibromyalgia Therapeutics Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Fibromyalgia Therapeutics Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Fibromyalgia Therapeutics Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Fibromyalgia Therapeutics Drugs Manufacturer Market Share in 2021
3.5 Global Fibromyalgia Therapeutics Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Fibromyalgia Therapeutics Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fibromyalgia Therapeutics Drugs Market Size by Region
4.1.1 Global Fibromyalgia Therapeutics Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Fibromyalgia Therapeutics Drugs Revenue by Region (2017-2028)
4.2 North America Fibromyalgia Therapeutics Drugs Revenue (2017-2028)
4.3 Europe Fibromyalgia Therapeutics Drugs Revenue (2017-2028)
4.4 Asia-Pacific Fibromyalgia Therapeutics Drugs Revenue (2017-2028)
4.5 South America Fibromyalgia Therapeutics Drugs Revenue (2017-2028)
4.6 Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Fibromyalgia Therapeutics Drugs Sales in Volume by Type (2017-2028)
5.2 Global Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2028)
5.3 Global Fibromyalgia Therapeutics Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Fibromyalgia Therapeutics Drugs Sales in Volume by Application (2017-2028)
6.2 Global Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2028)
6.3 Global Fibromyalgia Therapeutics Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Fibromyalgia Therapeutics Drugs Sales by Type (2017-2028)
7.2 North America Fibromyalgia Therapeutics Drugs Sales by Application (2017-2028)
7.3 North America Fibromyalgia Therapeutics Drugs Market Size by Country
7.3.1 North America Fibromyalgia Therapeutics Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Fibromyalgia Therapeutics Drugs Sales by Type (2017-2028)
8.2 Europe Fibromyalgia Therapeutics Drugs Sales by Application (2017-2028)
8.3 Europe Fibromyalgia Therapeutics Drugs Market Size by Country
8.3.1 Europe Fibromyalgia Therapeutics Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Fibromyalgia Therapeutics Drugs Market Size by Region
9.3.1 Asia-Pacific Fibromyalgia Therapeutics Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Fibromyalgia Therapeutics Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Fibromyalgia Therapeutics Drugs Sales by Type (2017-2028)
10.2 South America Fibromyalgia Therapeutics Drugs Sales by Application (2017-2028)
10.3 South America Fibromyalgia Therapeutics Drugs Market Size by Country
10.3.1 South America Fibromyalgia Therapeutics Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fibromyalgia Therapeutics Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Fibromyalgia Therapeutics Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Fibromyalgia Therapeutics Drugs Market Size by Country
11.3.1 Middle East & Africa Fibromyalgia Therapeutics Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Fibromyalgia Therapeutics Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Fibromyalgia Therapeutics Drugs
12.3 Fibromyalgia Therapeutics Drugs Production Process
12.4 Fibromyalgia Therapeutics Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Fibromyalgia Therapeutics Drugs Typical Distributors
13.3 Fibromyalgia Therapeutics Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Fibromyalgia Therapeutics Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Fibromyalgia Therapeutics Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Fibromyalgia Therapeutics Drugs Product and Services
Table 6. Pfizer Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly Major Business
Table 9. Eli Lilly Fibromyalgia Therapeutics Drugs Product and Services
Table 10. Eli Lilly Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Actavis Basic Information, Manufacturing Base and Competitors
Table 12. Actavis Major Business
Table 13. Actavis Fibromyalgia Therapeutics Drugs Product and Services
Table 14. Actavis Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Sharp and Dohme Basic Information, Manufacturing Base and Competitors
Table 16. Merck Sharp and Dohme Major Business
Table 17. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product and Services
Table 18. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 20. Daiichi Sankyo Major Business
Table 21. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product and Services
Table 22. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Innovative Med Concepts Basic Information, Manufacturing Base and Competitors
Table 24. Innovative Med Concepts Major Business
Table 25. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product and Services
Table 26. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Meda Basic Information, Manufacturing Base and Competitors
Table 28. Meda Major Business
Table 29. Meda Fibromyalgia Therapeutics Drugs Product and Services
Table 30. Meda Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Meiji Seika Basic Information, Manufacturing Base and Competitors
Table 32. Meiji Seika Major Business
Table 33. Meiji Seika Fibromyalgia Therapeutics Drugs Product and Services
Table 34. Meiji Seika Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Switch Biotech Basic Information, Manufacturing Base and Competitors
Table 36. Switch Biotech Major Business
Table 37. Switch Biotech Fibromyalgia Therapeutics Drugs Product and Services
Table 38. Switch Biotech Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Theravance Basic Information, Manufacturing Base and Competitors
Table 40. Theravance Major Business
Table 41. Theravance Fibromyalgia Therapeutics Drugs Product and Services
Table 42. Theravance Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Zynerba Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Zynerba Pharmaceuticals Major Business
Table 45. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product and Services
Table 46. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Tonix Pharmaceuticals Holding Corp. (TNXP) Basic Information, Manufacturing Base and Competitors
Table 48. Tonix Pharmaceuticals Holding Corp. (TNXP) Major Business
Table 49. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product and Services
Table 50. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 52. Daiichi Sankyo Major Business
Table 53. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product and Services
Table 54. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Forest Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Forest Pharmaceuticals, Inc. Major Business
Table 57. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product and Services
Table 58. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 60. Boehringer Ingelheim GmbH Major Business
Table 61. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product and Services
Table 62. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Pierre Fabre Mdicament Basic Information, Manufacturing Base and Competitors
Table 64. Pierre Fabre Mdicament Major Business
Table 65. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product and Services
Table 66. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Fibromyalgia Therapeutics Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 68. Global Fibromyalgia Therapeutics Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Fibromyalgia Therapeutics Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Fibromyalgia Therapeutics Drugs Production Capacity by Company, (Kg): 2020 VS 2021
Table 71. Head Office and Fibromyalgia Therapeutics Drugs Production Site of Key Manufacturer
Table 72. Fibromyalgia Therapeutics Drugs New Entrant and Capacity Expansion Plans
Table 73. Fibromyalgia Therapeutics Drugs Mergers & Acquisitions in the Past Five Years
Table 74. Global Fibromyalgia Therapeutics Drugs Sales by Region (2017-2022) & (Kg)
Table 75. Global Fibromyalgia Therapeutics Drugs Sales by Region (2023-2028) & (Kg)
Table 76. Global Fibromyalgia Therapeutics Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Fibromyalgia Therapeutics Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg)
Table 79. Global Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg)
Table 80. Global Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Fibromyalgia Therapeutics Drugs Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Fibromyalgia Therapeutics Drugs Price by Type (2017-2022) & (USD/g)
Table 83. Global Fibromyalgia Therapeutics Drugs Price by Type (2023-2028) & (USD/g)
Table 84. Global Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg)
Table 85. Global Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg)
Table 86. Global Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Fibromyalgia Therapeutics Drugs Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Fibromyalgia Therapeutics Drugs Price by Application (2017-2022) & (USD/g)
Table 89. Global Fibromyalgia Therapeutics Drugs Price by Application (2023-2028) & (USD/g)
Table 90. North America Fibromyalgia Therapeutics Drugs Sales by Country (2017-2022) & (Kg)
Table 91. North America Fibromyalgia Therapeutics Drugs Sales by Country (2023-2028) & (Kg)
Table 92. North America Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Fibromyalgia Therapeutics Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg)
Table 95. North America Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg)
Table 96. North America Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg)
Table 97. North America Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg)
Table 98. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2017-2022) & (Kg)
Table 99. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2023-2028) & (Kg)
Table 100. Europe Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Fibromyalgia Therapeutics Drugs Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg)
Table 103. Europe Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg)
Table 104. Europe Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg)
Table 105. Europe Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg)
Table 106. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Region (2017-2022) & (Kg)
Table 107. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Region (2023-2028) & (Kg)
Table 108. Asia-Pacific Fibromyalgia Therapeutics Drugs Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Fibromyalgia Therapeutics Drugs Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg)
Table 111. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg)
Table 112. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg)
Table 113. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg)
Table 114. South America Fibromyalgia Therapeutics Drugs Sales by Country (2017-2022) & (Kg)
Table 115. South America Fibromyalgia Therapeutics Drugs Sales by Country (2023-2028) & (Kg)
Table 116. South America Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Fibromyalgia Therapeutics Drugs Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg)
Table 119. South America Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg)
Table 120. South America Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg)
Table 121. South America Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg)
Table 122. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales by Region (2017-2022) & (Kg)
Table 123. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales by Region (2023-2028) & (Kg)
Table 124. Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg)
Table 127. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg)
Table 128. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg)
Table 129. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg)
Table 130. Fibromyalgia Therapeutics Drugs Raw Material
Table 131. Key Manufacturers of Fibromyalgia Therapeutics Drugs Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Fibromyalgia Therapeutics Drugs Typical Distributors
Table 135. Fibromyalgia Therapeutics Drugs Typical Customers
List of Figures
Figure 1. Fibromyalgia Therapeutics Drugs Picture
Figure 2. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type in 2021
Figure 3. Cymbalta (Duloxetine)
Figure 4. Savella (Milnacipran)
Figure 5. Lyrica (Pregabalin)
Figure 6. Pancuronium
Figure 7. Others
Figure 8. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application in 2021
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Fibromyalgia Therapeutics Drugs Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 13. Global Fibromyalgia Therapeutics Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Fibromyalgia Therapeutics Drugs Sales (2017-2028) & (Kg)
Figure 15. Global Fibromyalgia Therapeutics Drugs Price (2017-2028) & (USD/g)
Figure 16. Global Fibromyalgia Therapeutics Drugs Production Capacity (2017-2028) & (Kg)
Figure 17. Global Fibromyalgia Therapeutics Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Fibromyalgia Therapeutics Drugs Market Drivers
Figure 19. Fibromyalgia Therapeutics Drugs Market Restraints
Figure 20. Fibromyalgia Therapeutics Drugs Market Trends
Figure 21. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Manufacturer in 2021
Figure 22. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Manufacturer in 2021
Figure 23. Fibromyalgia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Fibromyalgia Therapeutics Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Fibromyalgia Therapeutics Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2017-2028)
Figure 27. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2017-2028)
Figure 28. North America Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Europe Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (USD Million)
Figure 31. South America Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 34. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 35. Global Fibromyalgia Therapeutics Drugs Price by Type (2017-2028) & (USD/g)
Figure 36. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 37. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 38. Global Fibromyalgia Therapeutics Drugs Price by Application (2017-2028) & (USD/g)
Figure 39. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 40. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 41. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2017-2028)
Figure 42. North America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2017-2028)
Figure 43. United States Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 47. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 48. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2017-2028)
Figure 49. Europe Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2017-2028)
Figure 50. Germany Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2017-2028)
Figure 59. China Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 66. South America Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 67. South America Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2017-2028)
Figure 68. South America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Fibromyalgia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Fibromyalgia Therapeutics Drugs in 2021
Figure 80. Manufacturing Process Analysis of Fibromyalgia Therapeutics Drugs
Figure 81. Fibromyalgia Therapeutics Drugs Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の線維筋痛症治療薬市場2022年：シンバルタ（デュロキセチン）、サベラ（ミルナシプラン）、リリカ（プレガバリン）、パンクロニウム、その他(Global Fibromyalgia Therapeutics Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の抗ウイルス剤市場2022年：逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系調節剤
  • 世界の制吐薬市場2022年：ドーパミン拮抗薬、5-HT-3受容体拮抗薬、NK1受容体拮抗薬、カンナビノイド受容体拮抗薬
  • 世界の抗肥満治療薬市場2022年：末梢性抗肥満薬、中枢性抗肥満薬
  • 世界のアレルギー性鼻炎治療薬市場2022年：抗ヒスタミン薬、鼻腔内コルチコステロイド、免疫療法
  • 世界の脂質注射薬市場2022年：イントラリピッド、リポシンIII、スモフリピッド、クリノリピッド、その他